Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy
Authors
Keywords
-
Journal
Science Advances
Volume 6, Issue 41, Pages eabc7031
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-10-10
DOI
10.1126/sciadv.abc7031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic Brain Delivery of Antisense Oligonucleotides across the Blood-Brain Barrier with a Glucose-Coated Polymeric Nanocarrier
- (2020) Hyun Su Min et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain
- (2020) Jinbing Xie et al. ACS Nano
- APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
- (2020) Axel Montagne et al. NATURE
- Clearance of two organic nanoparticles from the brain via the paravascular pathway
- (2020) Xiao Gu et al. JOURNAL OF CONTROLLED RELEASE
- ROS‐Responsive Polymeric siRNA Nanomedicine Stabilized by Triple Interactions for the Robust Glioblastoma Combinational RNAi Therapy
- (2019) Meng Zheng et al. ADVANCED MATERIALS
- BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
- (2019) Nour M. Moussa‐Pacha et al. MEDICINAL RESEARCH REVIEWS
- Neuropeptide S Ameliorates Cognitive Impairment of APP/PS1 Transgenic Mice by Promoting Synaptic Plasticity and Reducing Aβ Deposition
- (2019) Peng Zhao et al. Frontiers in Behavioral Neuroscience
- Evidence for brain glucose dysregulation in Alzheimer's disease
- (2018) Yang An et al. Alzheimers & Dementia
- Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease
- (2018) Pengzhen Wang et al. JOURNAL OF CONTROLLED RELEASE
- Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy
- (2018) Meng Zheng et al. TRENDS IN BIOTECHNOLOGY
- Novel Object Recognition as a Facile Behavior Test for Evaluating Drug Effects in AβPP/PS1 Alzheimer's Disease Mouse Model
- (2018) Ru Zhang et al. JOURNAL OF ALZHEIMERS DISEASE
- Effectiveness and Cost-Effectiveness of the Pharmacological Treatment of Alzheimer's Disease and Vascular Dementia
- (2018) Jan Versijpt JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
- (2017) Axel Montagne et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease
- (2017) Federica Prati et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dementia prevention, intervention, and care
- (2017) Gill Livingston et al. LANCET
- Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
- (2017) Sergey O. Bachurin et al. MEDICINAL RESEARCH REVIEWS
- Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
- (2017) Y. Anraku et al. Nature Communications
- Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening
- (2016) Peter Man-Un Ung et al. ACS Chemical Biology
- Drug treatments in Alzheimers disease
- (2016) R. Briggs et al. CLINICAL MEDICINE
- Does Nanomedicine Have a Delivery Problem?
- (2016) Michael Torrice ACS Central Science
- Cancer nanomedicine: is targeting our target?
- (2016) Twan Lammers et al. Nature Reviews Materials
- Nanomedicine and neurodegenerative disorders: so close yet so far
- (2015) Giovanni Tosi et al. Expert Opinion on Drug Delivery
- Axonal and Schwann Cell BACE1 Is Equally Required for Remyelination of Peripheral Nerves
- (2015) X. Hu et al. JOURNAL OF NEUROSCIENCE
- Astrocytes from adult Wistar rats aged in vitro show changes in glial functions
- (2015) Débora Guerini Souza et al. NEUROCHEMISTRY INTERNATIONAL
- Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines
- (2014) Daniela Puzzo et al. BIOCHEMICAL PHARMACOLOGY
- Burrowing and nest building behavior as indicators of well-being in mice
- (2014) Paulin Jirkof JOURNAL OF NEUROSCIENCE METHODS
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
- (2014) Robert Vassar Alzheimers Research & Therapy
- Amyloid-β and Tau
- (2014) George S. Bloom JAMA Neurology
- Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story
- (2013) Andrew Stamford et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- The Role of Glucose Transporters in Brain Disease: Diabetes and Alzheimer's Disease
- (2012) Kaushik Shah et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Age and gene overexpression interact to abolish nesting behavior in Tg2576 amyloid precursor protein (APP) mice
- (2010) Daniel W. Wesson et al. BEHAVIOURAL BRAIN RESEARCH
- High-Density Lipoprotein Facilitates In Vivo Delivery of α-Tocopherol–Conjugated Short-Interfering RNA to the Brain
- (2010) Yoshitaka Uno et al. HUMAN GENE THERAPY
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- Hydrophobic modifications of cationic polymers for gene delivery
- (2010) Zonghua Liu et al. PROGRESS IN POLYMER SCIENCE
- Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease
- (2009) Mohammed Filali et al. BRAIN RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now